Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry?

TG Therapeutics Inc common stock (TGTX) is near the top in its industry group according to InvestorsObserver. TGTX gets an overall rating of 58. That means it scores higher than 58 percent of stocks. TG Therapeutics Inc common stock gets a 76 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.

TGTX has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on TGTX!

See Full TGTX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With TG Therapeutics Inc common stock Stock Today?

TG Therapeutics Inc common stock (TGTX) stock is trading at $11.96 as of 12:58 PM on Friday, Nov 17, an increase of $0.70, or 6.22% from the previous closing price of $11.26. The stock has traded between $11.28 and $12.09 so far today. Volume today is low. So far 2,529,859 shares have traded compared to average volume of 7,179,973 shares. Click Here to get the full Stock Report for TG Therapeutics Inc common stock stock.